スポンサーリンク
Central Research Laboratories, Kyorin Pharmaceutical Co., Ltd. | 論文
- Synthesis of Metabolites and Related Compounds of 3-Isobutyryl-2-isopropylpyrazolo[1,5-α]pyridine (Ibudilast). III. 6,7-Dihydrodiol
- Synthesis of Metabolites and Related Compounds of 3-Isobutyryl-2-isopropylpyrazolo[1,5-α]pyridine (Ibudilast). II. Metabolites of Pyridine Ring
- Synthesis of Metabolites and Related Compounds of 3-Isobutyryl-2-isopropylpyrazolo[1,5-α]pyridine (Ibudilast). I. Metabolites of Alkyl Side Chains
- Synthesis of 3-Substituted Pyrazolo[1,5-a]pyridine Derivatives with Inhibitoruy Activity on Platelet Aggregation. II
- Synthesis of 3-Substituted Pyrazolo[1,5-a]pyridine Derivatives with Inhibitory Activity on Platelet Aggregation. I
- Estimation of Hydrophobicity Based on the Solvent-Accessible Surface Area of Molecules
- Application of Chemical P-450 Model Systems to Study Drug Metabolism. III. : Metabolism of 3-Isobutyryl-2-isopropylpyrazolo[1,5-α]pyridine
- FACILE PREPARATION OF UNSTABLE METABOLIC INTERMEDIATES : EPOXIDE(S) OF PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES BY THE CYTOCHROME P-450 CHEMICAL MODEL
- A04 INFLUENCE OF STARVATION ON TOXICITY STUDIES IN RATS
- ELECTROPHYSIOLOGICAL INVESTIGATIONS ON THE MODE OF ACTION OF NEFOPAM, A NOVEL ANALGESIC AGENT
- KC-404: A potential anti-allergic agent with antagonistic action against slow reacting substance of anaphylaxis.